 |
PDBsum entry 1mvc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
1mvc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Molecular recognition of agonist ligands by rxrs.
|
 |
|
Authors
|
 |
P.F.Egea,
A.Mitschler,
D.Moras.
|
 |
|
Ref.
|
 |
Mol Endocrinol, 2002,
16,
987-997.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The nuclear receptor RXR is an obligate partner in many signal transduction
pathways. We report the high-resolution structures of two complexes of the human
RXRalpha ligand-binding domain specifically bound to two different and
chemically unrelated agonist compounds: docosa hexaenoic acid, a natural
derivative of eicosanoic acid, present in mammalian cells and recently
identified as a potential endogenous RXR ligand in the mouse brain, and the
synthetic ligand BMS 649. In both structures the RXR-ligand-binding domain forms
homodimers and exhibits the active conformation previously observed with
9-cis-RA. Analysis of the differences in ligand-protein contacts (predominantly
van der Waals forces) and binding cavity geometries and volumes for the several
agonist-bound RXR structures clarifies the structural features important for
ligand recognition. The L-shaped ligand-binding pocket adapts to the diverse
ligands, especially at the level of residue N306, which might thus constitute a
new target for drug-design. Despite its highest affinity 9-cis-RA displays the
lowest number of ligand-protein contacts. These structural results support the
idea that docosa hexaenoic acid and related fatty acids could be natural
agonists of RXRs and question the real nature of the endogenous ligand(s) in
mammalian cells.
|
 |
|
|
|
|
 |